Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001221590-26-000009

Director bought 1,000 shares at $10.58 ($10,580)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BIENAIME JEAN JACQUES · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-15 Purchase : show line 1 in the form 10b5-1 +1,000 $10.58 $10,580 9,450 D
Open-market purchases · 1,000 sh · avg $10.58 · $10,580
Loading xslF345X06/form4-05192026_040503.xml…